Why the study?
Does KW-4679 or terfenadine prolong action potential duration in isolated guinea pig ventricular myocytes?
Does KW-4679 or terfenadine prolong action potential duration in isolated guinea pig ventricular myocytes?
Unlike terfenadine, the novel antiallergic compound KW-4679 does not prolong action potential duration in preclinical models, suggesting a lower proarrhythmic risk.
Answers are grounded in this paper and cite their sources.
May support lower proarrhythmic risk for KW-4679; leaves open clinical translation in humans.
It has been reported that terfenadine caused torsade de pointes ventricular arrhythmias. The prolongation of action potential duration (APD) in ventricles is considered to be one of the mechanisms of this adverse effect. We examined the effect of antiallergic drugs, terfenadine and KW-4679 ((Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b, e]oxepin- 2-acetic acid hydrochloride), on action potentials in isolated guinea pig ventricular myocytes. Terfenadine (30 nM-1 microM) increased APD in a concentration-dependent manner. On the other hand, KW-4679 (0.1 microM-100 microM) exerted no significant effects on action potential parameters. These results present no evidence that KW-4679 has the possibility to cause ventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
Kato et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: